Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting

November 8, 2022

https://www.globenewswire.com/news-release/2022/11/08/2550667/0/en/Masonic-Cancer-Center-University-of-Minnesota-to-Present-Data-in-Poster-Presentation-From-the-Phase-1-Clinical-Trial-to-Evaluate-HCW9218-in-Solid-Tumors-At-the-SITC-37th-Annual-Mee.html

Presentation includes data on safety and dosage escalation
and immune system reaction to HCW9218

No incidence of mucosal bleeding resulting from the HCW9218 TGF-β trap

Read more at globenewswire.com

Related news for (HCWB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.